Healthcare provider profile · identity verified

Madhusudan Menon, MD

Internal Medicine · PITTSBURGH, PA · NPI 1528046570

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	690	186
Atorvastatin Calcium	Atorvastatin Calcium	588	173
Pantoprazole Sodium	Pantoprazole Sodium	513	137
Rosuvastatin Calcium	Rosuvastatin Calcium	431	121
Losartan Potassium	Losartan Potassium	417	116
Levothyroxine Sodium	Levothyroxine Sodium	346	79
Lisinopril	Lisinopril	322	81
Hydrochlorothiazide	Hydrochlorothiazide	280	70
Gabapentin	Gabapentin	267	54
Furosemide	Furosemide	254	69
Eliquis	Apixaban	243	56
Metformin Hcl	Metformin Hcl	230	76
Albuterol Sulfate Hfa	Albuterol Sulfate	217	67
Trazodone Hcl	Trazodone Hcl	215	45
Tamsulosin Hcl	Tamsulosin Hcl	187	50
Escitalopram Oxalate	Escitalopram Oxalate	181	45
Omeprazole	Omeprazole	179	51
Carvedilol	Carvedilol	169	47
Metoprolol Succinate	Metoprolol Succinate	169	57
Potassium Chloride	Potassium Chloride	148	44
Simvastatin	Simvastatin	146	39
Metoprolol Tartrate	Metoprolol Tartrate	141	42
Atenolol	Atenolol	130	32
Fluticasone Propionate	Fluticasone Propionate	127	62
Famotidine	Famotidine	121	31
Jardiance	Empagliflozin	113	29
Clopidogrel	Clopidogrel Bisulfate	98	23
Meloxicam	Meloxicam	91	21
Alendronate Sodium	Alendronate Sodium	90	29
Alprazolam	Alprazolam	89	16
Ezetimibe	Ezetimibe	84	24
Sertraline Hcl	Sertraline Hcl	83	24
Tramadol Hcl	Tramadol Hcl	74	20
Montelukast Sodium	Montelukast Sodium	73	20
Warfarin Sodium	Warfarin Sodium	72	suppressed
Citalopram Hbr	Citalopram Hydrobromide	68	11
Synthroid	Levothyroxine Sodium	64	20
Ozempic	Semaglutide	61	17
Spironolactone	Spironolactone	61	15
Glimepiride	Glimepiride	60	17
Breo Ellipta	Fluticasone/Vilanterol	59	12
Solifenacin Succinate	Solifenacin Succinate	58	19
Paroxetine Hcl	Paroxetine Hcl	56	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	20
Lorazepam	Lorazepam	55	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	53	12
Hydroxyzine Hcl	Hydroxyzine Hcl	53	19
Ibuprofen	Ibuprofen	51	23
Pravastatin Sodium	Pravastatin Sodium	49	14
Bumetanide	Bumetanide	48	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	suppressed
Allopurinol	Allopurinol	47	17
Duloxetine Hcl	Duloxetine Hcl	47	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Clonazepam	Clonazepam	46	suppressed
Mirtazapine	Mirtazapine	45	11
Finasteride	Finasteride	44	17
Digoxin	Digoxin	41	11
Methocarbamol	Methocarbamol	40	16
Pregabalin	Pregabalin	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Primidone	Primidone	38	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	37	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	11
Prednisone	Prednisone	36	18
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Dofetilide	Dofetilide	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Prolia	Denosumab	32	19
Valsartan	Valsartan	32	11
Celecoxib	Celecoxib	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Topiramate	Topiramate	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	11
Klor-Con M20	Potassium Chloride	30	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	12
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Irbesartan	Irbesartan	28	suppressed
Labetalol Hcl	Labetalol Hcl	28	suppressed
Folic Acid	Folic Acid	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	11
Levetiracetam	Levetiracetam	26	suppressed
Linzess	Linaclotide	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Ibandronate Sodium	Ibandronate Sodium	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Temazepam	Temazepam	20	suppressed
Vilazodone Hcl	Vilazodone Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	13
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Baclofen	Baclofen	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	16
Glipizide	Glipizide	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Ibu	Ibuprofen	16	suppressed
Indomethacin	Indomethacin	16	suppressed
Naproxen	Naproxen	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	11
Phenobarbital	Phenobarbital	13	suppressed
Ramipril	Ramipril	13	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error